Switch View
© PR Newswire
09.09.2025
ISIN: CA05156X8504
Aurora Cannabis Inc
ACB
LISTED
NASDAQ
Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case Studies
News Preview
NASDAQ | TSX: ACB
EDMONTON, AB, Sept. 9, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announced the launch of the English-language version of the Physician Experience Platform (PEP), in collaboration with German healthcare technology leader, Copeia. Developed as a pe...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: CA1699161032
Chitogenx Inc.
CHGX
LISTED
CSE
CHITOGENX ANNOUNCES SIGNING OF BINDING LETTER OF INTENT WITH OLIGO MEDIC INC., ISSUANCE OF PARTIAL REVOCATION ORDER, AND FINANCING
News Preview
/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/
MONTREAL, Sept. 9, 2025 /CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), today confirms that it has entered into a binding letter of intent (the "LOI") dated September 8, 2025 with Oligo Medic Inc. ("Oligo Medic"), a private Can...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: CA05156X8504
Aurora Cannabis Inc
ACB
LISTED
NASDAQ
Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case Studies
News Preview
NASDAQ | TSX: ACB
EDMONTON, AB, Sept. 9, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announced the launch of the English-language version of the Physician Experience Platform (PEP), in collaboration with German healthcare technology leader, Copeia. Developed...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
09.09.2025
ISIN: US6402683063
Nektar Therapeutics
NKTR
LISTED
NASDAQ
Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025
News Preview
SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that it will present results from the ongoing REZOLVE-AD Phase 2b study at the 2025 European Academy of Dermatology and Venereology (EADV) Congress being held in Paris, France from September 17-20, 2025....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
09.09.2025
ISIN: US09073M1045
Bio-Techne Corp
TECH
LISTED
NASDAQ
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
News Preview
ST. PAUL, Minn., Sept. 9, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8) G-Rex Grants, totaling nearly $2 million in support, have been awarded to awardees of the California Institute for Regenerative Medicine (CIRM) Manufacturin...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment
News Preview
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
New offering expands Lilly Catalyze360's support for early-stage drug development
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machi...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ION582 for the treatment of Angelman syndrome (AS), a rare neurological disease that often presents in infancy and is characterized by profound intellectual disability, impaired communication,...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
News Preview
The latest AI-powered feature in Counterpart Assistant streamlines documentation, enhances physician workflows, and raises the bar for value-based care across practice settings at no additional cost to users The latest AI-powered feature in Counterpart Assistant streamlines documentation, enhances physician workflows, and raises the bar for value-b...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US74907L3006
Quoin Pharmaceuticals Ltd.
QNRX
LISTED
NASDAQ
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome
News Preview
New Episode Highlights the Social and Emotional Impact of Netherton Syndrome, the Importance of Supportive Communities, and the Urgent Need for an Approved Treatment New Episode Highlights the Social and Emotional Impact of Netherton Syndrome, the Importance of Supportive Communities, and the Urgent Need for an Approved Treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
News Preview
- Transaction affirms the strength of Elutia’s proprietary drug-eluting biologics platform and fully funds advancement of NXT-41 in breast reconstruction -...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit
News Preview
Highlighting Continued Progress with EMA Regarding a Potential Conditional Marketing Authorization Submission for Iopofosine I 131 to Treat Waldenstrom Macroglobulinemia (WM) in the EU; Decision on Track for Late 3Q25/Early 4Q25...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: CA4229102088
Helix Biopharma Corp.
HBP
LISTED
TSX
Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
News Preview
TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vincible, is pleased to announce that the Company will present at the Q3 2025 Investor Summit V...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
09.09.2025
ISIN: US89157D1054
Tourmaline Bio Inc
TALS
LISTED
NASDAQ
TRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Tourmaline Bio, Inc. (NASDAQ: TRML) to Novartis AG for $48.00 per share in cash is fair to Tourmaline shareholders.
Halper Sadeh encourages Tourmaline shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.09.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Berenberg startet Coverage mit „Kauf“-Empfehlung und Kursziel von 24 € – Kurspotenzial 47%
News Preview
Berlin, 9. September 2025. Die Eckert & Ziegler SE (ISIN DE0005659700), ein führender Anbieter von isotopentechnischen Komponenten für Nuklearmedizin und Messtechnik, wird künftig von der Hamburger Privatbank Joh. Berenberg, Gossler & Co. KG bewertet. In ihrer Initialstudie sprechen die Analysten eine „Kauf“-Empfehlung mit einem Kursziel vo......
Themefolio
Profiler
Peergroup
© EQS Newswire
09.09.2025
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
News Preview
Berlin, 9 September 2025. Eckert & Ziegler SE (ISIN DE0005659700), a leading supplier of isotope technology components for nuclear medicine and measurement technology, will be rated by the Hamburg-based private bank Joh. Berenberg, Gossler & Co. KG from now on. In their initial study, the analysts issue a “Buy” recommendation with a price t......
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US0327973006
Anavex Life Sciences Corp
AVXL
LISTED
NASDAQ
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial
News Preview
New clinical Precision Medicine population 48-week data demonstrates unprecedented cognitive stabilization in early Alzheimer’s disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US05356F1057
Aveanna Healthcare Holdings Inc
AVAH
LISTED
NASDAQ
Aveanna to Participate at the Jefferies Healthcare Services Conference
News Preview
ATLANTA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Jefferies Healthcare Services Conference in Nashville on September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US82657M1053
Sight Sciences Inc
SGHT
LISTED
NASDAQ
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
News Preview
UnitedHealthcare’s Coverage Policy includes procedures enabled with OMNI Surgical System technology, the leader in implant-free MIGS, are proven and medically necessary UnitedHealthcare’s Coverage Policy includes procedures enabled with OMNI Surgical System technology, the leader in implant-free MIGS, are proven and medically necessary...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Breckenridge Brewery Awarded Silver Certification by the Colorado Green Business Network for Excellence in Sustainability Practices
News Preview
LITTLETON, Colo., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a craft brewery owned by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), is proud to announce it has received the Silver Certification from the Colorado Green Business Network (CGBN), recognizing the brewery’s ongoing commitment to sustainability and environmenta...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions
News Preview
Castle will share new data on its TissueCypher Barrett’s Esophagus test via a podium presentation on Sept. 13 at the AFS 2025 Annual Meeting....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US00461U1051
Aclaris Therapeutics Inc
ACRS
LISTED
NASDAQ
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress
News Preview
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation at the 2025 European Academy of Dermatology and Ve...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer
News Preview
Late-breaking data from exploratory analyses at WCLC show Libtayo plus chemotherapy demonstrates a more than double five-year overall survival rate of 19.4%, compared to 8.8% with chemotherapy alone...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: CA72706K1012
Planet 13 Holdings Inc.
PLTH
LISTED
CSE
Delicious Fast-Acting HaHa Soft Chews, Top Sellers at Planet 13 Las Vegas, are Now Available in Florida at Planet 13 Dispensaries across the Sunshine State
News Preview
Made with real Fruit Juices, HaHa Soft Chews (AKA gummies) are vegan, gluten-free, and melt-resistant. This is just the beginning for Planet 13’s Florida edibles offerings, with Sugar-free HaHa and Dreamland Chocolates coming soon. Made with real Fruit Juices, HaHa Soft Chews (AKA gummies) are vegan, gluten-free, and melt-resistant. This is just th...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Projects Debt-Free Status by Year-End Driven by Strong Subsidiary Growth
News Preview
"Company anticipates achieving debt-free status by year-end, reinforcing commitment to AI-driven healthcare technologies" MESA, ARIZONA / ACCESS Newswire / September 9, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging leader in AI-driven healthcare innovation, today announced that based on current subsidiary performance,...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma, Inc. Receives Third Award from the NIA for Excellence in Code Clarity, Reproducibility, and Usability for Alzheimer's Detection
News Preview
POTOMAC, MD / ACCESS Newswire / September 9, 2025 / IGC Pharma, Inc. (NYSE American:IGC), a clinical-stage pharmaceutical company focused on therapies for Alzheimer's disease, today announced that its Artificial Intelligence (AI) team has been recognized with a special award for excellence in clean code development as part of the National Institute...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
News Preview
Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery and biodefense company, today announced the launch of a transformer-based platform that embeds biological risk intelligence...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US89157D1054
Tourmaline Bio Inc
TALS
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Tourmaline Bio, Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
The Ademi Firm is investigating Tourmaline (NASDAQ: TRML) for possible breaches of fiduciary duty and other violations of law in its transaction with a Novartis.
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to yo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: US6300872032
NanoViricides, Inc.
NNVC
LISTED
XASE
NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
News Preview
SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Wednesday, September 17th, at 12:30pm at the Life Science Executive Pa...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy
News Preview
New preclinical findings highlight Telomir-1's ability to reverse CDKN2A gene silencing by DNA methylation, reactivating this gene - often called the body's natural "cell cycle brake." These results build on prior STAT1 data, supporting Telomir-1's profile as a potential first-in-class broad-spectrum DNA methylation reset therapy. MIAMI,...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.09.2025
ISIN: CH1243598427
Sandoz Group AG
SDZ
LISTED
XWSX
Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar
News Preview
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules
Agreement clears path for launch of Enzeevu™ (aflibercept-abzv) by end of 2026
Enzeevu™ is an FDA-approved Sandoz biosimilar to Eylea®
Anticipated launch further strengthens Sandoz biosimilar portfolio, advances growth strategy in US and ensures more patients have access to......
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR INVESTOR ALERT: Kirby McInerney LLP Notifies Capricor Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
News Preview
Kirby McInerney LLP reminds Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) investors of the September 15, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action.
If you purchased or otherwise acquired Capricor securities, have information, or would like to learn more, please contac...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2025
ISIN: US89157D1054
Tourmaline Bio Inc
TALS
LISTED
NASDAQ
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
News Preview
– Novartis to acquire Tourmaline Bio for $48.00 per share in cash for a total equity value of approximately $1.4 billion –...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: BE0003755692
AGFA Gevaert NV
AGFB
LISTED
EURONEXT
Elevating Imaging, Empowering Flow - AGFA HealthCare at RSNA 2025
News Preview
Enabling clinicians to stay in flow-anytime, anywhere-with an intelligent, cloud-powered Enterprise Imaging Platform that is streaming-enabled, deeply integrated, and tailored to your workspace. CARLSTADT, NEW JERSEY / ACCESS Newswire / September 9, 2025 / At RSNA 2025, AGFA HealthCare will unveil its latest suite of imaging innovations designed to...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Investor Alert: Robbins LLP Informs Investors of the Savara Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 8, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Savara Inc. (NASAQ: SVRA) securities between March 7, 2024 and May 23, 2025. Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. The C...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
News Preview
THOUSAND OAKS, Calif. and TOKYO, Sept. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (TSE: 4151) today announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an investigational T-cell rebalancing therapy targeting the OX40 receptor, in adults and adolescents with moderate to severe atopic de...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: GB0034330679
Angle plc
AGL
LISTED
AIMX
Angle PLC Announces Interim Results
News Preview
ANGLE plc("ANGLE" or "the Company")Interim Results for the six months ended 30 June 2025COMMERCIALISATION PROGRESSED ACROSS MULTIPLE FRONTS DESPITE REVENUE PRESSURE FROM ADVERSE MARKET CONDITIONSLarge pharma contracts completed successfullyDNA Dual Analysis Illumina NGS assay for CTC-DNA and ctDNA developed GUILDFORD, SURREY / A...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.09.2025
ISIN: GB0034330679
Angle plc
AGL
LISTED
AIMX
Angle PLC Announces Change of Adviser
News Preview
APPOINTMENT OF NOMINATED ADVISER AND SOLE BROKER GUILDFORD, SURREY / ACCESS Newswire / September 9, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce that it has appointed Cavendish...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors
News Preview
Johnson & Johnson (NYSE: JNJ) announced today that John Morikis, retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, has been elected to its Board of Directors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908666514/en/John Morikis headshot...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.09.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors
News Preview
VANCOUVER, BC / ACCESS Newswire / September 8, 2025 / Lobe Sciences Ltd. ("Lobe Sciences" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce the appointment of Mr. Marco Mastr...
Themefolio
Profiler
Peergroup
© Newsfile
08.09.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
Stonegate Capital Partners Initiates Coverage on OS Therapies Inc. (OSTX)
News Preview
Dallas, Texas--(Newsfile Corp. - September 8, 2025) - OS Therapies Inc. (NYSE American: OSTX): Stonegate Capital Partners initiates their coverage on OS Therapies Inc. (NYSE American: OSTX). OS Therapies advanced meaningful clinical, regulatory, and financial milestones in 2Q25 as it moves closer to bringing OST-HER2 to patients with recu...
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
DEADLINE APPROACHING: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025
News Preview
PHILADELPHIA, Sept. 8, 2025 /PRNewswire/ -- Berger Montague PC, a national securities litigation law firm announces it is investigating potential securities fraud claims involving RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST), following the recent filing of a federal securities class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces New Employment Inducement Grants
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase a total of 19,300 shares of the...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum
News Preview
Johnson & Johnson (NYSE: JNJ) will present at the Bernstein 2nd Annual Healthcare Forum on Wednesday, September 24th, 2025. Management will participate in a Fireside Chat at 1:10 p.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. A...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes
News Preview
Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028 (the “notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the S...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: US0042251084
ACADIA Pharmaceuticals Inc
ACAD
LISTED
NASDAQ
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on September 4, 2025, the Compensation Committee of Acadia’s Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 161,676 shares of common stock and 49,363 restricted stock units (“RSUs”) to eighteen new employees under A...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: US0887861088
Bicycle Therapeutics plc
BCYC
LISTED
NASDAQ
Bicycle Therapeutics Strengthens Board of Directors with New Appointments
News Preview
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointments of Roger Dansey, M.D., and Hervé Hoppenot to the company’s Board of Directors.
"We are thrilled to welcome Roger and Hervé to...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to five newly hired non-executive employees consisting of options to purchase an aggregate of 78,750 common...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis to host investors and analysts for Innovation Day 2025
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it will host Ionis Innovation Day on Tuesday, October 7, 2025, in New York.
The agenda will feature presentations from members of the Ionis leadership team as well as a key thought leader in the treatment of severe hypertriglyceridemia, familial chylomicronemia syndrome and lipid di...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.09.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
News Preview
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $250.0 million aggregate principal amount of 8.625% senior unsecured notes due 2030 (the “2030 Notes”). The 2030 No...
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ: EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFMD
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. ("LifeMD" or the "Company")(NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. - LNTH
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: US74006W2070
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX
News Preview
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or the "Company") (NASDAQ: PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
08.09.2025
ISIN: DE0005550602
Draegerwerk AG & Co KGaA
DRW8
LISTED
XETR
Dräger Selected to Exhibit Polaris at Vizient Innovative Technology Exchange
News Preview
TELFORD, Pa., Sept. 8, 2025 /PRNewswire/ -- Dräger has been selected to exhibit its new Polaris surgical light at the Vizient® Innovative Technology Exchange. Vizient, the nation's largest provider-driven healthcare performance improvement company, will hold the Exchange on September 17 in Las Vegas....
Themefolio
Profiler
Peergroup
© Newsfile
08.09.2025
ISIN: CA68405U1012
Optimind Pharma Corp.
OMND
LISTED
CSE
Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk
News Preview
Toronto, Ontario--(Newsfile Corp. - September 8, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") is pleased to announce that it has entered into a binding definitive share exchange agreement dated September 5, 2025 (the "SEA") with IDesk Technologies Private Limited ("InterviewDesk"), a private company incorporated under...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
